{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T14:44:47Z","timestamp":1792334687543,"version":"4.4.0"},"reference-count":63,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dysregulation of the skin microbiome is implicated in acne pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate the efficacy of probiotics in the management of acne.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Searches were conducted in 3 databases through June 30, 2024. Clinical trials that compared probiotics with controls and investigated their efficacy in acne were included. Primary outcomes were standardized mean differences (SMDs) for the change from baseline to posttreatment in total lesion count (TLC), noninflammatory lesion count (NILC), and inflammatory lesion count (ILC). Secondary outcomes included Global Acne Grading System (GAGS) scores, Investigator\u2019s Global Assessment, erythema, and sebum levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Thirteen studies comprising 18 study arms and 1453 participants were included. There were no significant reductions in TLC (SMD, \u22120.22; 95% confidence interval [CI]: \u22120.50 to 0.07;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200975%), NILC (SMD, \u22120.20; 95% CI: \u22120.48 to 0.08;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200972%), or ILC (SMD, \u22120.13; 95% CI: \u22120.34 to 0.09;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200952%) with probiotics compared with controls. However, oral probiotics were associated with a significant reduction in GAGS scores (SMD, \u22120.47; 95% CI: \u22120.81 to \u22120.13;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200967%) versus controls. Subgroup analyses indicated that this effect was most prominent in mild-to-moderate acne patients who received oral probiotics containing\n                      <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                      species combined with other strains for a minimum of 12\u2009weeks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Probiotics did not demonstrate a significant reduction in acne lesion counts. However, they were associated with improvements in acne severity as measured by GAGS scores. These findings should be interpreted with caution given the heterogeneity across studies and the fluctuating natural course of acne.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/12034754261445880","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:03:37Z","timestamp":1779192217000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Probiotics in Managing Acne Vulgaris: A Systematic Review and Meta-Analysis of Clinical Trials"],"prefix":"10.1177","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-1170","authenticated-orcid":false,"given":"Narachai","family":"Julanon","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand"},{"name":"Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-5615","authenticated-orcid":false,"given":"Chanita","family":"Unhapipatpong","sequence":"additional","affiliation":[{"name":"Division of Clinical Nutrition, Department of Medicine, Khon Kaen Hospital, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-5250","authenticated-orcid":false,"given":"Rachot","family":"Wongjirattikarn","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2654-8637","authenticated-orcid":false,"given":"Thanaphon","family":"Anutraungkool","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8954-7672","authenticated-orcid":false,"given":"Suteeraporn","family":"Chaowattanapanit","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3417-6210","authenticated-orcid":false,"given":"Charoen","family":"Choonhakarn","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3570-8474","authenticated-orcid":false,"given":"Kittisak","family":"Sawanyawisuth","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand"},{"name":"Sleep Apnea Research Group, Research Center in Back, Neck and Other Joint Pain and Human Performance, Khon Kaen University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-3245","authenticated-orcid":false,"given":"Prapimporn Chattranukulchai","family":"Shantavasinkul","sequence":"additional","affiliation":[{"name":"Division of Nutrition and Biochemical Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Graduate Program in Nutrition, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, ON, Canada"},{"name":"Division of Dermatology, Department of Medicine, Women College Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105302"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19540"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071303"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20332"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02836-1"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.3949"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.017"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13776"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14355"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140665"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081086"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000055"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034938"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00099.x"},{"key":"e_1_3_3_16_2","unstructured":"Center for Drug Evaluation and Research. Acne vulgaris: establishing effectiveness of drugs intended for treatment. 2020. Accessed January 18 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/acne-vulgaris-establishing-effectiveness-drugs-intended-treatment"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_3_19_2","unstructured":"Cochrane. Chapter 25. Assessing risk of bias in a non-randomized study. Accessed January 16 2025. https:\/\/training.cochrane.org\/handbook\/current\/chapter-25"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02493-0"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_3_22_2","unstructured":"IBM Corp. IBM SPSS Statistics for Windows. Version 29.0.2.0 [computer software]. Armonk (NY): IBM Corp.; 2023."},{"key":"e_1_3_3_23_2","unstructured":"The Cochrane Collaboration. Review Manager (RevMan) [computer software]. Version 5.4. Copenhagen: The Nordic Cochrane Centre The Cochrane Collaboration; 2020."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i23.5415"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-022-1520-6"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15228"},{"issue":"7","key":"e_1_3_3_27_2","first-page":"206","article-title":"Therapy of acne with","volume":"17","author":"Stuttgen G.","year":"1991","unstructured":"Stuttgen G. Therapy of acne with Saccaromyces boulardii. Aktuelle Derm. 1991;17(7):206-209.","journal-title":"Saccaromyces boulardii. Aktuelle Derm"},{"issue":"26","key":"e_1_3_3_28_2","first-page":"563","article-title":"Treatment of acne with a yeast preparation","volume":"107","author":"Weber G","year":"1989","unstructured":"Weber G, Adamczyk A, Freytag S. [Treatment of acne with a yeast preparation]. Fortschr Med. 1989;107(26):563-566.","journal-title":"Fortschr Med"},{"key":"e_1_3_3_29_2","unstructured":"Kitkuakosol S Khunngam P. The effectiveness of probiotic in the treatment of inflamed acne. 2019. Accessed December 31 2024. https:\/\/www.semanticscholar.org\/paper\/The-Effectiveness-of-Probiotic-in-The-Treatment-of-Kitkuakosol-Khunngam\/de52e2fdcfd9fb253aeb194fd7f4a35c20602e2a"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.33206"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2023.05.516"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041368"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14971"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.5935\/scd1984-8773.2023150225"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00664-z"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1340068"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.18.05710-3"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030895"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2012.12026"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100521"},{"key":"e_1_3_3_41_2","unstructured":"ClinicalTrials.gov. Clinical trial in subjects with mild to moderate acne vulgaris. Bethesda (MD): U.S. National Library of Medicine. Accessed December 31 2024. https:\/\/clinicaltrials.gov\/study\/NCT02832063?viewType=Card&id=NCT02832063&rank=1"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-01079-8"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16614"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/1757-4749-3-1"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2009.06.016"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092160"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.578386"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904055107"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62715-3"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020666"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020411"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753465810379009"},{"issue":"6","key":"e_1_3_3_53_2","first-page":"560","article-title":"An open label, phase 2 study of MABp1 monotherapy for the treatment of acne vulgaris and psychiatric comorbidity","volume":"14","author":"Carrasco D","year":"2015","unstructured":"Carrasco D, Stecher M, Lefebvre GC, Logan AC, Moy R. An open label, phase 2 study of MABp1 monotherapy for the treatment of acne vulgaris and psychiatric comorbidity. J Drugs Dermatol. 2015;14(6):560-564.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.3920\/BM2016.0089"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu16111691"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1252972"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.3168\/jds.S0022-0302(06)72104-X"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.12.026"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145103"},{"issue":"9","key":"e_1_3_3_60_2","first-page":"868","article-title":"Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius","volume":"5","author":"Bowe WP","year":"2006","unstructured":"Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006;5(9):868-870.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-008-0179-y"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA119000279"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20061"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19856"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754261445880","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754261445880","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754261445880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T14:17:40Z","timestamp":1792333060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/12034754261445880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/12034754261445880"],"URL":"https:\/\/doi.org\/10.1177\/12034754261445880","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}